Drugs

Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases
Vincenzo Papa, Paolo Rama, Cherry Radford, Darwin C Minassian, John K G Dart

British Journal of Ophthalmology Apr 2020, 104 (4) 575-581; DOI: 10.1136/bjophthalmol-2019-314485
Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Heather Waterman, Simon Read, James Edwards Morgan, David Gillespie, Claire Nollett, Davina Allen, Marjorie Weiss, Pippa Anderson

British Journal of Ophthalmology Mar 2020, bjophthalmol-2019-315436; DOI: 10.1136/bjophthalmol-2019-315436
Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression
Aicun Fu, Fiona Stapleton, Li Wei, Weiqun Wang, Bingxin Zhao, Kathleen Watt, Na Ji, Yong Lyu

British Journal of Ophthalmology Feb 2020, bjophthalmol-2019-315440; DOI: 10.1136/bjophthalmol-2019-315440
Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial
Jeremy A Lavine, Sunil K Srivastava, Neeley Dukles, Jamie L Reese, Justis P Ehlers

British Journal of Ophthalmology Mar 2020, 104 (3) 410-415; DOI: 10.1136/bjophthalmol-2019-314142
Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Anne Hedengran, Alvilda T Steensberg, Gianni Virgili, Augusto Azuara-Blanco, Miriam Kolko

British Journal of Ophthalmology Feb 2020, bjophthalmol-2019-315623; DOI: 10.1136/bjophthalmol-2019-315623
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens
Alessandro Invernizzi, Francesco Pichi, Richard Symes, Sophia Zagora, Aniruddha Kishandutt Agarwal, Phuc Nguyen, Stefano Erba, Alba Xhepa, Luca De Simone, Luca Cimino, Mark C Gillies, Peter J McCluskey

British Journal of Ophthalmology Nov 2019, bjophthalmol-2019-315257; DOI: 10.1136/bjophthalmol-2019-315257
Safety of 6000 intravitreal dexamethasone implants
Bindu Rajesh, Javier Zarranz-Ventura, Adrian T Fung, Catharina Busch, Niroj Kumar Sahoo, Patricio J Rodriguez-Valdes, Valentina Sarao, Sanjay Kumar Mishra, A Osman Saatci, Patricia Udaondo Mirete, Giuseppe Querques, Michel Eid Farah, Paolo Lanzetta, J Fernando Arevalo, Laurent Kodjikian, Jay Chhablani

British Journal of Ophthalmology Jan 2020, 104 (1) 39-46; DOI: 10.1136/bjophthalmol-2019-313991
Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort
Nieraj Jain, Alexa L Li, Yinxi Yu, Brian L VanderBeek

British Journal of Ophthalmology Nov 2019, bjophthalmol-2019-314765; DOI: 10.1136/bjophthalmol-2019-314765
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
Augusto Azuara-Blanco, Nicola Logan, Niall Strang, Kathryn Saunders, Peter M Allen, Ruth Weir, Paul Doherty, Catherine Adams, Evie Gardner, Ruth Hogg, Margaret McFarland, Jennifer Preston, Rejina Verghis, James J Loughman, Ian Flitcroft, David A Mackey, Samantha Sze-Yee Lee, Christopher Hammond, Nathan Congdon, Mike Clarke

British Journal of Ophthalmology Oct 2019, bjophthalmol-2019-314819; DOI: 10.1136/bjophthalmol-2019-314819
ACE inhibitor use and risk of cataract: a case–control analysis
Claudia Becker, Susan S Jick, Christoph R Meier

British Journal of Ophthalmology Nov 2019, 103 (11) 1561-1565; DOI: 10.1136/bjophthalmol-2018-312980

Main menu

Drugs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Drugs

Pages